Eli Lilly
As on 25 Oct, 2025 | 01:29 IST
| Open | 815.78 |
| Previous Close | 821.04 |
| Beta | 0.42 |
| High | 833.99 |
| Low | 806.32 |
| TTM EPS See historical trend | 16.15(+77.67% YoY) |
| 52 Week High | 935.37 |
| 52 Week Low | 623.99 |
| TTM PE See historical trend | 51.14(Low PE) |
| Mkt. Cap ($ Billion) | 785.18 |
| Dividend Yield | 0.74 |
Advanced Chart
*Delayed by 20 seconds.
MC Technicals
| Days | |
|---|---|
| 5 | 813.55 |
| 10 | 816.19 |
| 20 | 812.54 |
| 50 | 764.78 |
| 100 | 765.68 |
| 200 | 786.26 |
Returns
| 1 Week | 2.93% | |
| 1 Month | 11.32% | |
| 3 Months | 2.61% | |
| YTD | 7.05% | |
| 1 Year | -7.47% | |
| 3 Years | 137.38% |
Financialsin million $
Peers
| Name | Price ($) | Change% | M.Cap(Billion $) | TTM PE | TTM EPS | DY | 52 wk high/low | Technical Rating | |
|---|---|---|---|---|---|---|---|---|---|
| Eli Lilly | 825.84 | 0.58 | 785.18 | 51.14 | 16.15 | 0.74 | 935.37/623.99 | 11.32 | Very Bullish |
| J&J | 190.42 | -1.07 | 458.87 | 18.34 | 10.38 | 2.83 | 194.47/141.30 | 7.80 | Very Bullish |
| AbbVie | 228.04 | -0.09 | 402.98 | 21.53 | 10.59 | 3.49 | 244.80/163.83 | 3.66 | Neutral |
| Merck | 87.48 | 0.34 | 221.56 | 11.45 | 7.64 | 4.04 | 105.86/73.35 | 9.83 | Very Bullish |
| Abbott | 126.85 | 0.40 | 220.02 | 25.42 | 4.99 | 1.76 | 141.07/110.89 | -5.26 | Very Bearish |
Market news
- Wall Street ends higher as investors digest Trump trade commentsOctober 18, 2025 8:37 AM
- Wall Street sells off as Trump hits China with more tariffsOctober 11, 2025 8:32 AM
- Dow, S&P 500 manage record closing highs; Nasdaq falls in volatile sessionOctober 4, 2025 9:34 AM
- Wall Street closes higher, boosted by healthcare as investors shrug off jobs data, US shutdownOctober 2, 2025 8:05 AM
About the company
Eli Lilly and Company is a drug manufacturing company. The Company discover, develop, manufacture, and market products in a human pharmaceutical product segment. The Company’s products include Diabetes and other endocrinology products, including Baqsimi, Basaglar, Forteo, Humalog, Humatrope, Humulin, Jardiance, Trajenta and Trulicity. Its Immunology products include Olumiant and Taltz. Its Neuroscience products include Cymbalta, Emgality, Reyvow, Strattera and Zyprexa. Its Oncology products include Alimta, Cyramza, Erbitux and Verzenio. Other product includes Cialis, for the tratment of erectile dysfunction and benign prostatic hyperplasia. The Company manufacture and distribute its products through facilities in the United States, Puerto Rico, and 8 other countries. Its products are sold in approximately 120 countries.